Impact of Treatments on Cancer-Related Fatigue: A Meta-Analysis

Introduction to Cancer-Related Fatigue (CRF)

Cancer-related fatigue (CRF) presents a significant challenge for patients battling cancer, as it can adversely affect their quality of life and overall survival. This condition can hinder patients’ ability to undergo treatment and manage daily activities. Symptoms such as depression, anxiety, pain, and insomnia often exacerbate the severity of CRF.

Study Overview

A recent meta-analysis published in JAMA Oncology reviewed 113 randomized clinical trials to evaluate the effectiveness of various treatment methods for CRF. These studies exclusively focused on patients aged 18 and older, utilizing CRF severity as a primary outcome measure. The analysis excluded studies involving erythropoietin-stimulating agents and alternative therapies.

Demographics of the Study Population

The meta-analysis encompassed 11,525 patients, with a majority being female (78%) and most studies focusing on breast cancer (46.9%). The interventions analyzed included 14 studies on pharmaceutical treatments, 10 on combined exercise and psychological approaches, 34 on psychological therapies, and 69 on exercise alone.

Findings on Treatment Efficacy

All intervention types studied demonstrated improvements in CRF among patients. Exercise therapy emerged as the most effective approach, regardless of whether it was anaerobic, aerobic, or a combination of both. In contrast, pharmacological treatments, which included medications like paroxetine and methylphenidate, exhibited the least effectiveness in alleviating CRF.

The combination of exercise and psychological treatment did reduce CRF; however, the results were inconsistent. In some cases, the combined effect was similar to or less effective than the individual treatments. Notably, the most significant improvement in CRF was observed in patients with early-stage cancer and those who had completed primary treatment. Cognitive behavioral therapy proved to be more effective than other psychological interventions, while exercise was particularly beneficial for patients undergoing primary treatment.

Implications for Clinical Practice

This meta-analysis provides valuable insights that may aid clinicians in establishing guidelines for managing CRF. Despite the large number of studies included and a low risk of bias, the research had limitations, such as a lack of demographic diversity and unclear definitions of CRF as a primary or secondary outcome in some studies.

Future clinical trials should prioritize CRF reduction as the primary outcome and investigate a broader range of treatments, including exercise, psychological, pharmacological, and combination therapies. Based on the findings, physicians are encouraged to consider exercise and psychological interventions as the first-line treatments for CRF.

Conclusion

In summary, the meta-analysis highlights the effectiveness of various treatment modalities for managing cancer-related fatigue. The results underscore the importance of incorporating exercise and psychological support into treatment plans for patients experiencing CRF.

Written By: Corey Cunningham, PharmD